161 related articles for article (PubMed ID: 32889079)
21. Molecular mechanisms of interleukin-10-mediated inhibition of NF-kappaB activity: a role for p50.
Driessler F; Venstrom K; Sabat R; Asadullah K; Schottelius AJ
Clin Exp Immunol; 2004 Jan; 135(1):64-73. PubMed ID: 14678266
[TBL] [Abstract][Full Text] [Related]
22. Semaphorin 7A interacts with nuclear factor NF-kappa-B p105 via integrin β1 and mediates inflammation.
Li X; Xie W; Pan Q; Zhang X; Zhang L; Zhao N; Xie Q; Ding J; Chai J
Cell Commun Signal; 2023 Jan; 21(1):24. PubMed ID: 36717921
[TBL] [Abstract][Full Text] [Related]
23. Defective activation of ERK in macrophages lacking the p50/p105 subunit of NF-kappaB is responsible for elevated expression of IL-12 p40 observed after challenge with Helicobacter hepaticus.
Tomczak MF; Gadjeva M; Wang YY; Brown K; Maroulakou I; Tsichlis PN; Erdman SE; Fox JG; Horwitz BH
J Immunol; 2006 Jan; 176(2):1244-51. PubMed ID: 16394015
[TBL] [Abstract][Full Text] [Related]
24. Modification by single ubiquitin moieties rather than polyubiquitination is sufficient for proteasomal processing of the p105 NF-kappaB precursor.
Kravtsova-Ivantsiv Y; Cohen S; Ciechanover A
Mol Cell; 2009 Feb; 33(4):496-504. PubMed ID: 19250910
[TBL] [Abstract][Full Text] [Related]
25. Detrimental
Fliegauf M; Kinnunen M; Posadas-Cantera S; Camacho-Ordonez N; Abolhassani H; Alsina L; Atschekzei F; Bogaert DJ; Burns SO; Church JA; Dückers G; Freeman AF; Hammarström L; Hanitsch LG; Kerre T; Kobbe R; Sharapova SO; Siepermann K; Speckmann C; Steiner S; Verma N; Walter JE; Westermann-Clark E; Goldacker S; Warnatz K; Varjosalo M; Grimbacher B
Front Immunol; 2022; 13():965326. PubMed ID: 36105815
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of ubiquitin-mediated, limited processing of the NF-kappaB1 precursor protein p105.
Ciechanover A; Gonen H; Bercovich B; Cohen S; Fajerman I; Israël A; Mercurio F; Kahana C; Schwartz AL; Iwai K; Orian A
Biochimie; 2001; 83(3-4):341-9. PubMed ID: 11295495
[TBL] [Abstract][Full Text] [Related]
27. Processing of p105 is inhibited by docking of p50 active subunits to the ankyrin repeat domain, and inhibition is alleviated by signaling via the carboxyl-terminal phosphorylation/ ubiquitin-ligase binding domain.
Cohen S; Orian A; Ciechanover A
J Biol Chem; 2001 Jul; 276(29):26769-76. PubMed ID: 11350967
[TBL] [Abstract][Full Text] [Related]
28. Shared pathways of IkappaB kinase-induced SCF(betaTrCP)-mediated ubiquitination and degradation for the NF-kappaB precursor p105 and IkappaBalpha.
Heissmeyer V; Krappmann D; Hatada EN; Scheidereit C
Mol Cell Biol; 2001 Feb; 21(4):1024-35. PubMed ID: 11158290
[TBL] [Abstract][Full Text] [Related]
29. HTLV-I encoded Tax in association with NF-kappa B precursor p105 enhances nuclear localization of NF-kappa B p50 and p65 in transfected cells.
Watanabe M; Muramatsu M; Hirai H; Suzuki T; Fujisawa J; Yoshida M; Arai K; Arai N
Oncogene; 1993 Nov; 8(11):2949-58. PubMed ID: 8414497
[TBL] [Abstract][Full Text] [Related]
30. Induction of the transcription factor Sp1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/p50 NF-kappaB promoters.
Yurochko AD; Mayo MW; Poma EE; Baldwin AS; Huang ES
J Virol; 1997 Jun; 71(6):4638-48. PubMed ID: 9151857
[TBL] [Abstract][Full Text] [Related]
31. PAFR activation of NF-κB p65 or p105 precursor dictates pro- and anti-inflammatory responses during TLR activation in murine macrophages.
Ishizuka EK; Filgueiras LR; Rios FJ; Serezani CH; Jancar S
Sci Rep; 2016 Aug; 6():32092. PubMed ID: 27554194
[TBL] [Abstract][Full Text] [Related]
32. The 20S proteasome processes NF-kappaB1 p105 into p50 in a translation-independent manner.
Moorthy AK; Savinova OV; Ho JQ; Wang VY; Vu D; Ghosh G
EMBO J; 2006 May; 25(9):1945-56. PubMed ID: 16619030
[TBL] [Abstract][Full Text] [Related]
33. Ubiquitin-mediated processing of NF-kappa B transcriptional activator precursor p105. Reconstitution of a cell-free system and identification of the ubiquitin-carrier protein, E2, and a novel ubiquitin-protein ligase, E3, involved in conjugation.
Orian A; Whiteside S; Israël A; Stancovski I; Schwartz AL; Ciechanover A
J Biol Chem; 1995 Sep; 270(37):21707-14. PubMed ID: 7665588
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of transcription by B cell Leukemia 3 (Bcl-3) protein requires interaction with nuclear factor κB (NF-κB) p50.
Collins PE; Kiely PA; Carmody RJ
J Biol Chem; 2014 Mar; 289(10):7059-7067. PubMed ID: 24459141
[TBL] [Abstract][Full Text] [Related]
35. Association between activation of atypical NF-kappaB1 p105 signaling pathway and nuclear beta-catenin accumulation in colorectal carcinoma.
Lauscher JC; Gröne J; Dullat S; Hotz B; Ritz JP; Steinhoff U; Buhr HJ; Visekruna A
Mol Carcinog; 2010 Feb; 49(2):121-9. PubMed ID: 20027638
[TBL] [Abstract][Full Text] [Related]
36. Suppression of monocyte chemoattractant protein 1, but not IL-8, by alprazolam: effect of alprazolam on c-Rel/p65 and c-Rel/p50 binding to the monocyte chemoattractant protein 1 promoter region.
Oda T; Ueda A; Shimizu N; Handa H; Kasahara T
J Immunol; 2002 Sep; 169(6):3329-35. PubMed ID: 12218154
[TBL] [Abstract][Full Text] [Related]
37. NFKB1: a suppressor of inflammation, ageing and cancer.
Cartwright T; Perkins ND; L Wilson C
FEBS J; 2016 May; 283(10):1812-22. PubMed ID: 26663363
[TBL] [Abstract][Full Text] [Related]
38. The p105/50 NF-kappaB pathway is essential for Mallory body formation.
Nan L; Wu Y; Bardag-Gorce F; Li J; French BA; Wilson LT; French SW
Exp Mol Pathol; 2005 Jun; 78(3):198-206. PubMed ID: 15924871
[TBL] [Abstract][Full Text] [Related]
39. NF-κB1 p105 suppresses lung tumorigenesis through the Tpl2 kinase but independently of its NF-κB function.
Sun F; Qu Z; Xiao Y; Zhou J; Burns TF; Stabile LP; Siegfried JM; Xiao G
Oncogene; 2016 May; 35(18):2299-310. PubMed ID: 26300007
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis B virus HBx protein activates transcription factor NF-kappaB by acting on multiple cytoplasmic inhibitors of rel-related proteins.
Su F; Schneider RJ
J Virol; 1996 Jul; 70(7):4558-66. PubMed ID: 8676482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
